Unbound MEDLINE

Genetic polymorphisms in folate pathway enzymes as a possible marker for predicting the outcome of methotrexate therapy in Japanese patients with rheumatoid arthritis. Journal of clinical pharmacy and therapeutics [J Clin Pharm Ther] Journal article

 
TitleGenetic polymorphisms in folate pathway enzymes as a possible marker for predicting the outcome of methotrexate therapy in Japanese patients with rheumatoid arthritis.
Author(s)Hayashi H, Fujimaki C, Daimon T, Tsuboi S, Matsuyama T, Itoh K 
InstitutionDepartment of Clinical Pharmacology and Genetics, School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan
SourceJ Clin Pharm Ther 2009 Jun; 34(3):355-61.
Languageeng
Pub Type(s)Journal Article
PubMed ID19827168
  
Advertise on this site.